Advances in multimodal molecular imaging

Luigi Auletta, Matteo Gramanzini, Sara Gargiulo, Sandra Albanese, Marco Salvatore, Adelaide Greco

Research output: Contribution to journalReview article

Abstract

Preclinical molecular imaging is an emerging field. Improving the ability of scientists to study the molecular basis of human pathology in animals is of the utmost importance for future advances in all fields of human medicine. Moreover, the possibility of developing new imaging techniques or of implementing old ones adapted to the clinic is a significant area. Cardiology, neurology, immunology and oncology have all been studied with preclinical molecular imaging. The functional techniques of photoacoustic imaging (PAI), fluorescence molecular tomography (FMT), positron emission tomography (PET), and single photon emission computed tomography (SPECT) in association with each other or with the anatomic reference provided by computed tomography (CT) as well as with anatomic and functional information provided by magnetic resonance (MR) have all been proficiently applied to animal models of human disease. All the above-mentioned imaging techniques have shown their ability to explore the molecular mechanisms involved in animal models of disease. The clinical translatability of most of the techniques motivates the ongoing study of their possible fields of application. The ability to combine two or more techniques allows obtaining as much information as possible on the molecular processes involved in pathologies, reducing the number of animals necessary in each experiment. Merging molecular probes compatible with various imaging technique will further expand the capability to achieve the best results.

Original languageEnglish
Pages (from-to)19-32
Number of pages14
JournalQuarterly Journal of Nuclear Medicine and Molecular Imaging
Volume61
Issue number1
DOIs
Publication statusPublished - Mar 1 2017

Fingerprint

Multimodal Imaging
Molecular Imaging
Animal Disease Models
Photoacoustic Techniques
Tomography
Pathology
Molecular Probes
Optical Imaging
Neurology
Allergy and Immunology
Single-Photon Emission-Computed Tomography
Cardiology
Positron-Emission Tomography
Magnetic Resonance Spectroscopy
Medicine

Keywords

  • Animal model
  • Multimodal imaging
  • Nuclear microscopy
  • Optical imaging
  • Photoacoustic techniques
  • Ultrasonography

ASJC Scopus subject areas

  • Medicine(all)
  • Radiology Nuclear Medicine and imaging

Cite this

Advances in multimodal molecular imaging. / Auletta, Luigi; Gramanzini, Matteo; Gargiulo, Sara; Albanese, Sandra; Salvatore, Marco; Greco, Adelaide.

In: Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 61, No. 1, 01.03.2017, p. 19-32.

Research output: Contribution to journalReview article

Auletta, Luigi ; Gramanzini, Matteo ; Gargiulo, Sara ; Albanese, Sandra ; Salvatore, Marco ; Greco, Adelaide. / Advances in multimodal molecular imaging. In: Quarterly Journal of Nuclear Medicine and Molecular Imaging. 2017 ; Vol. 61, No. 1. pp. 19-32.
@article{ab3376d9271d4501ae4d0c404a15e403,
title = "Advances in multimodal molecular imaging",
abstract = "Preclinical molecular imaging is an emerging field. Improving the ability of scientists to study the molecular basis of human pathology in animals is of the utmost importance for future advances in all fields of human medicine. Moreover, the possibility of developing new imaging techniques or of implementing old ones adapted to the clinic is a significant area. Cardiology, neurology, immunology and oncology have all been studied with preclinical molecular imaging. The functional techniques of photoacoustic imaging (PAI), fluorescence molecular tomography (FMT), positron emission tomography (PET), and single photon emission computed tomography (SPECT) in association with each other or with the anatomic reference provided by computed tomography (CT) as well as with anatomic and functional information provided by magnetic resonance (MR) have all been proficiently applied to animal models of human disease. All the above-mentioned imaging techniques have shown their ability to explore the molecular mechanisms involved in animal models of disease. The clinical translatability of most of the techniques motivates the ongoing study of their possible fields of application. The ability to combine two or more techniques allows obtaining as much information as possible on the molecular processes involved in pathologies, reducing the number of animals necessary in each experiment. Merging molecular probes compatible with various imaging technique will further expand the capability to achieve the best results.",
keywords = "Animal model, Multimodal imaging, Nuclear microscopy, Optical imaging, Photoacoustic techniques, Ultrasonography",
author = "Luigi Auletta and Matteo Gramanzini and Sara Gargiulo and Sandra Albanese and Marco Salvatore and Adelaide Greco",
year = "2017",
month = "3",
day = "1",
doi = "10.23736/S1824-4785.16.02943-5",
language = "English",
volume = "61",
pages = "19--32",
journal = "Quarterly Journal of Nuclear Medicine and Molecular Imaging",
issn = "1824-4785",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "1",

}

TY - JOUR

T1 - Advances in multimodal molecular imaging

AU - Auletta, Luigi

AU - Gramanzini, Matteo

AU - Gargiulo, Sara

AU - Albanese, Sandra

AU - Salvatore, Marco

AU - Greco, Adelaide

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Preclinical molecular imaging is an emerging field. Improving the ability of scientists to study the molecular basis of human pathology in animals is of the utmost importance for future advances in all fields of human medicine. Moreover, the possibility of developing new imaging techniques or of implementing old ones adapted to the clinic is a significant area. Cardiology, neurology, immunology and oncology have all been studied with preclinical molecular imaging. The functional techniques of photoacoustic imaging (PAI), fluorescence molecular tomography (FMT), positron emission tomography (PET), and single photon emission computed tomography (SPECT) in association with each other or with the anatomic reference provided by computed tomography (CT) as well as with anatomic and functional information provided by magnetic resonance (MR) have all been proficiently applied to animal models of human disease. All the above-mentioned imaging techniques have shown their ability to explore the molecular mechanisms involved in animal models of disease. The clinical translatability of most of the techniques motivates the ongoing study of their possible fields of application. The ability to combine two or more techniques allows obtaining as much information as possible on the molecular processes involved in pathologies, reducing the number of animals necessary in each experiment. Merging molecular probes compatible with various imaging technique will further expand the capability to achieve the best results.

AB - Preclinical molecular imaging is an emerging field. Improving the ability of scientists to study the molecular basis of human pathology in animals is of the utmost importance for future advances in all fields of human medicine. Moreover, the possibility of developing new imaging techniques or of implementing old ones adapted to the clinic is a significant area. Cardiology, neurology, immunology and oncology have all been studied with preclinical molecular imaging. The functional techniques of photoacoustic imaging (PAI), fluorescence molecular tomography (FMT), positron emission tomography (PET), and single photon emission computed tomography (SPECT) in association with each other or with the anatomic reference provided by computed tomography (CT) as well as with anatomic and functional information provided by magnetic resonance (MR) have all been proficiently applied to animal models of human disease. All the above-mentioned imaging techniques have shown their ability to explore the molecular mechanisms involved in animal models of disease. The clinical translatability of most of the techniques motivates the ongoing study of their possible fields of application. The ability to combine two or more techniques allows obtaining as much information as possible on the molecular processes involved in pathologies, reducing the number of animals necessary in each experiment. Merging molecular probes compatible with various imaging technique will further expand the capability to achieve the best results.

KW - Animal model

KW - Multimodal imaging

KW - Nuclear microscopy

KW - Optical imaging

KW - Photoacoustic techniques

KW - Ultrasonography

UR - http://www.scopus.com/inward/record.url?scp=85014365866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014365866&partnerID=8YFLogxK

U2 - 10.23736/S1824-4785.16.02943-5

DO - 10.23736/S1824-4785.16.02943-5

M3 - Review article

AN - SCOPUS:85014365866

VL - 61

SP - 19

EP - 32

JO - Quarterly Journal of Nuclear Medicine and Molecular Imaging

JF - Quarterly Journal of Nuclear Medicine and Molecular Imaging

SN - 1824-4785

IS - 1

ER -